US Patent 7696170 Fibrosis inhibitor for implanted organ
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+341 characters)
Article
Patent abstract
A pharmaceutical preparation comprising a hepatocyte growth factor or a DNA molecule encoding the same and the like according to the present invention can suppress the fibrosis of a transplanted organ after organ transplantation. The present invention is useful in the fields of organ transplantation and regeneration therapy.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Jun Amano0
Kazuhiro Yamaura0
Ken-ichi Ito0
Kunio Matsumoto0
Toshikazu Nakamura0
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07696170 Fibrosis inhibitor for implanted organ US Patent 7696170 Fibrosis inhibitor for implanted organ
Infobox
Patent Number
076961700
Patent Number
76961700
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
076961700
Date of Patent
April 13, 2010
0Patent Application Number
117953140
Date Filed
September 9, 2005
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07696170 Fibrosis inhibitor for implanted organ
Infobox
Is a
Patent jurisdiction
Patent number
07696170
Date of patent
April 13, 2010
Patent application number
11795314
Date Filed
September 9, 2005
Patent primary examiner
Find more entities like US Patent 7696170 Fibrosis inhibitor for implanted organ
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.